Influence of 5-hydroxytryptamine on aortic valve competence in vitro

A H Chester1, M Misfeld, H H Sievers

  • 1Department of Cardiothoracic Surgery, Heart Science Centre, Harefield Hospital, NHLI, Imperial College of Science Technology and Medicine, Middlesex, UK.

Summary

The contractile agent 5-hydroxytryptamine (5-HT) increases aortic valve leakage by causing cusp tissue contraction via 5-HT2A receptors. This finding may explain links between 5-HT, appetite suppressants, and valve dysfunction.